CD69 and neoplasm: Tumor-infiltrating T cells with upregulated expression of activation markers, such as CD44, CD69, and CD25, and downregulated expression of exhaustion markers like PD-1 and CTLA-4 indicate a higher T-cell functional status that mediates a stronger and more enduring anti-tumor response [24,25].